SCHEMBL5013591

SCHEMBL5013591

COc1ccc(NC(=O)ON2N(Cc3ccc(C#N)cc3)C(=O)OC23CCCCC3)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 2/20 0.47
POLB P06746 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GRIN2B Q13224 1/20 0.44
KCNA5 P22460 1/20 0.43
USP2 O75604 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2D6 P10635 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
FPR2 P25090 6/20 0.41
FPR1 P21462 4/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5011684 0.88 LMNA (0.47) SMN1; SMN2CYP2D6ALDH1A1LMNAMAPT
SCHEMBL5012911 0.76 PPARG (0.36) TSHRSMN1; SMN2KDM4EHSD17B10GRIN2B
SCHEMBL4257403 0.76 TSHR (0.45) TSHRSMN1; SMN2KDM4EPOLBHSD17B10
SCHEMBL5013432 0.68 RAB9A (0.40) SMN1; SMN2POLBMEN1KMT2AALDH1A1
SCHEMBL5013344 0.67 CNR2 (0.38) TSHRSMN1; SMN2POLBHSD17B10USP2
SCHEMBL5016264 0.67 HPGD (0.38) TSHRSMN1; SMN2HSD17B10USP2CYP2C9
SCHEMBL5012930 0.66 CNR2 (0.38) TSHRHSD17B10USP2CYP2C9CYP1A2
SCHEMBL1949463 0.63 F9 (0.60) TSHRSMN1; SMN2KDM4EPOLBHSD17B10
SCHEMBL19570455 0.63 POLB (0.54) SMN1; SMN2POLBUSP2KMT2AALDH1A1
SCHEMBL12451587 0.62 TNF (0.55) TSHRSMN1; SMN2KDM4EPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910381-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-04-16 EP claimed
WO-2007000325-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-01-04 WO claimed
EP-1910381-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-04-16 EP disclosed
WO-2007000325-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-01-04 WO disclosed